Gartner Inc vs uniQure N.V. Ordinary Shares — how do they compare? Gartner Inc trades at $197.21 (market cap $12.44B), while uniQure N.V. Ordinary Shares trades at $20.78 (market cap $1.48B). The key difference: Gartner Inc is far larger — about 8.4× uniQure N.V. Ordinary Shares's market cap, and Gartner Inc is trading nearer its 52-week high, uniQure N.V. Ordinary Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Gartner Inc for 65 Days and uniQure N.V. Ordinary Shares for 0 Days on average.
| IT | QURE | |
|---|---|---|
Market Cap | $12.44B | $1.48B |
Volume | 818,587 | 2,488,780 |
Sector | Technology | Health |
52-Week High | $258.17 | $70.59 |
52-Week Low | $125.68 | $9.03 |
Typical Hold Time | 65 Days | 0 Days |
Enterprise Value | $14.18B | $728.62M |
Signals from Pluang's Aura AI — not financial advice
Gartner Inc. (IT) trades at $195.77, up 0.86% on the day, with a bullish technical signal and strong profitability metrics including a 69.63% gross margin and 113.58% ROE. Recent earnings beats and positive news flow around AI advisory demand support the stock, though net cash flow turned negative in 2025. The current price sits above the consensus target of $178.14, indicating potential overvaluation concerns among analysts.
Outlook remains positive due to robust contract value growth and AI-driven demand, but risks include volatile cash flows, high P/B ratio of 160.06, and a shareholder investigation. Investor sentiment is mixed with 55.55% hold ratings, suggesting cautious optimism amid execution risks and macroeconomic uncertainty.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Based in Stamford, Conn., Gartner provides independent research and analysis on information technology and other related technology industries. Its research is delivered to clients' desktops in the form of reports, briefings, and updates. Typical clients are chief information officers and other business executives who help plan companies' IT budgets. Gartner also provides consulting services and hosted nearly 80 IT conferences across the globe in 2007.
Read more on IT →uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.
Read more on QURE →